title: Efficacy of cetuximab for unresectable or advanced cutaneous squamous cell carcinoma--a report of eight cases.
authors.forename: D
authors.initials: D
authors.lastname: Giacchero
authors.forename: J
authors.initials: J
authors.lastname: Barrière
authors.forename: K
authors.initials: K
authors.lastname: Benezery
authors.forename: B
authors.initials: B
authors.lastname: Guillot
authors.forename: C
authors.initials: C
authors.lastname: Dutriaux
authors.forename: L
authors.initials: L
authors.lastname: Mortier
authors.forename: J P
authors.initials: JP
authors.lastname: Lacour
authors.forename: A
authors.initials: A
authors.lastname: Thyss
authors.forename: F
authors.initials: F
authors.lastname: Peyrade
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000532:radiotherapy; D000068818:Cetuximab; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab